Literature DB >> 8571134

Plasma viral load, CD4+ cell counts, and HIV-1 production by cells.

J A Levy, B Ramachandran, E Barker, J Guthrie, T Elbeik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8571134     DOI： 10.1126/science.271.5249.670

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  12 in total

1.  Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.

Authors:  A C Vicente; S M Agwale; K Otsuki; O M Njouku; D Jelpe; J A Idoko; E Caride; R M Brindeiro; A Tanuri
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.332

2.  Adenovirus expressing a bioluminescence reporter gene and cMAGI cell assay for the detection of HIV-1.

Authors:  Gadi Borkow; Humberto Herman Lara; Mila Ayash-Rashkovsky; Einat Tavor; Aviva Lapidot; Zvi Bentwich; Alik Honigman
Journal:  Virus Genes       Date:  2004-10       Impact factor: 2.332

3.  Costs versus benefits: best possible and best practical treatment regimens for HIV.

Authors:  O Krakovska; L M Wahl
Journal:  J Math Biol       Date:  2007-01-05       Impact factor: 2.259

4.  Detection of HIV-1 DNA in cells and tissue by fluorescent in situ 5'-nuclease assay (FISNA).

Authors:  B K Patterson; D Jiyamapa; E Mayrand; B Hoff; R Abramson; P M Garcia
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

5.  Surrogate markers now provide physicians with the best means to manage antiretroviral therapy: the case for.

Authors:  G J Moyle; B G Gazzard; T Peto
Journal:  Genitourin Med       Date:  1997-06

6.  Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.

Authors:  G Silvestri; C Munoz-Calleja; P Bagnarelli; G Piedimonte; M Clementi; M Montroni
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.

Authors:  N Sachsenberg; A S Perelson; S Yerly; G A Schockmel; D Leduc; B Hirschel; L Perrin
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

8.  Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events.

Authors:  E Yuste; S Sánchez-Palomino; C Casado; E Domingo; C López-Galíndez
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity.

Authors:  Kunyan Zhang; Farazana Rana; Claudia Silva; Julie Ethier; Kathy Wehrly; Bruce Chesebro; Christopher Power
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.

Authors:  Sabine Francke; Charles G Orosz; Jason Hsu; Lawrence E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.